DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer

✍ Scribed by Mariana C. Stern; Kathleen Conway; Yu Li; Kusum Mistry; Jack A. Taylor

• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 88 KB
• Volume: 45
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.20210

✦ Synopsis

We investigated if the presence of single nucleotide polymorphisms (SNPs) in the XRCC1, XRCC3, and XPD genes were associated with the type and frequency of p53 mutations in bladder cancer. Using a hospital-based case-control study we have previously reported risks for the XRCC1 codon 194, XRCC1 codon 399, XRCC3 codon 241, and XPD codon 751 SNPs [1][2][3]. We have also previously reported mutation data for 149 cases from this study who were screened for mutations in exons 4 through 9 of the p53 gene [4]. Here we investigate possible associations between the DNA repair SNPs mentioned above and the presence of p53 mutations by comparing the frequency of each genotype between p53 mutation positive and negative cases. We also considered different classes of p53 mutations, including any mutation (nonsense, missense or silent), transversions and transitions and estimated odds ratios (ORs) and 95% confidence intervals (CI) for these associations. Cases with the XRCC1 codon 399 Gln/Gln genotype were positively associated with the presence of p53 transversions (OR ¼ 4.8; 94% CI ¼ 0.8-30). Cases with the XPD codon 751 Gln/Gln genotype were positively associated with the presence of p53 transitions (OR ¼ 2.8; 95% CI ¼ 0.8-9.3), in particular G:C-A:T transitions (OR ¼ 3.7; 95% CI ¼ 1.1-13). Our data provide some limited support for the hypothesis that mutations in the p53 gene in bladder cancer may differ according to the presence or absence of certain DNA repair gene variants.